ETF Holdings Breakdown of INSM

News associated with INSM

Notable ETF Inflow Detected - VTWO, INSM, FTAI, CORT

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Russell 2000 (Symbol: VTWO) where we have detected an approximate $654.2 million dollar inflow -- that's a 6.1% increase week over week in o - 2025-05-07 14:54:13

Renaissance Technologies LLC Buys New Shares in Insmed Incorporated (NASDAQ:INSM)

Renaissance Technologies LLC bought a new stake in Insmed Incorporated (NASDAQ:INSM – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 25,287 shares of the biopharmaceutical company’s stock, valued at approximately $1,746,000. Other institutional investors have also recently added to or reduced […] - 2025-04-28 07:44:58

Cerity Partners LLC Sells 3,090 Shares of Insmed Incorporated (NASDAQ:INSM)

Cerity Partners LLC decreased its holdings in Insmed Incorporated (NASDAQ:INSM – Free Report) by 14.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,258 shares of the biopharmaceutical company’s stock after selling 3,090 shares during the quarter. Cerity Partners LLC’s holdings […] - 2025-04-18 08:06:53

Envestnet Asset Management Inc. Increases Stake in Insmed Incorporated (NASDAQ:INSM)

Envestnet Asset Management Inc. grew its position in Insmed Incorporated (NASDAQ:INSM – Free Report) by 6.3% in the 4th quarter, Holdings Channel reports. The institutional investor owned 256,358 shares of the biopharmaceutical company’s stock after purchasing an additional 15,227 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Insmed were worth $17,699,000 as of […] - 2025-04-16 07:56:51

Wells Fargo & Company MN Boosts Position in Insmed Incorporated (NASDAQ:INSM)

Wells Fargo & Company MN lifted its position in Insmed Incorporated (NASDAQ:INSM – Free Report) by 26.1% during the 4th quarter, HoldingsChannel reports. The firm owned 160,709 shares of the biopharmaceutical company’s stock after buying an additional 33,214 shares during the period. Wells Fargo & Company MN’s holdings in Insmed were worth $11,095,000 at the […] - 2025-04-16 07:24:55

IWM, SFM, INSM, FTAI: ETF Inflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 2000 ETF (Symbol: IWM) where we have detected an approximate $718.7 million dollar inflow -- that's a 1.2% increase week over week in - 2025-04-15 15:02:26

Corient Private Wealth LLC Has $1.02 Million Position in Insmed Incorporated (NASDAQ:INSM)

Corient Private Wealth LLC lifted its stake in Insmed Incorporated (NASDAQ:INSM – Free Report) by 34.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,730 shares of the biopharmaceutical company’s stock after acquiring an additional 3,747 shares during the quarter. Corient Private Wealth LLC’s […] - 2025-03-27 08:50:53

Envestnet Portfolio Solutions Inc. Increases Stock Holdings in Insmed Incorporated (NASDAQ:INSM)

Envestnet Portfolio Solutions Inc. increased its position in Insmed Incorporated (NASDAQ:INSM – Free Report) by 3.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,314 shares of the biopharmaceutical company’s stock after acquiring an additional 225 shares during the quarter. Envestnet Portfolio Solutions Inc.’s […] - 2025-03-27 08:04:55

Analysts Set Insmed Incorporated (NASDAQ:INSM) Target Price at $94.00

Insmed Incorporated (NASDAQ:INSM – Get Free Report) has been given a consensus recommendation of “Buy” by the sixteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Sixteen research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in the […] - 2025-03-26 05:52:54

Xponance Inc. Grows Stock Position in Insmed Incorporated (NASDAQ:INSM)

Xponance Inc. grew its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 23.1% during the fourth quarter, Holdings Channel reports. The institutional investor owned 12,689 shares of the biopharmaceutical company’s stock after purchasing an additional 2,380 shares during the quarter. Xponance Inc.’s holdings in Insmed were worth $876,000 as of its most […] - 2025-03-25 08:37:04

Royal Bank of Canada Reiterates Outperform Rating for Insmed (NASDAQ:INSM)

Insmed (NASDAQ:INSM – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Royal Bank of Canada in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $100.00 target price on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target points to a potential upside […] - 2025-03-21 06:42:57

26,995 Shares in Insmed Incorporated (NASDAQ:INSM) Bought by Proficio Capital Partners LLC

Proficio Capital Partners LLC bought a new stake in Insmed Incorporated (NASDAQ:INSM – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 26,995 shares of the biopharmaceutical company’s stock, valued at approximately $1,864,000. A number of other […] - 2025-03-20 09:04:51

Victory Capital Management Inc. Trims Stake in Insmed Incorporated (NASDAQ:INSM)

Victory Capital Management Inc. reduced its stake in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 10.0% in the 4th quarter, Holdings Channel reports. The fund owned 410,577 shares of the biopharmaceutical company’s stock after selling 45,382 shares during the period. Victory Capital Management Inc.’s holdings in Insmed were worth $28,346,000 as of its […] - 2025-03-11 08:15:01

Proficio Capital Partners LLC Invests $1.86 Million in Insmed Incorporated (NASDAQ:INSM)

Proficio Capital Partners LLC purchased a new stake in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 26,995 shares of the biopharmaceutical company’s stock, valued at approximately $1,864,000. A number of other hedge funds have also […] - 2025-03-07 09:09:10

Insmed Incorporated (NASDAQ:INSM) Shares Sold by QRG Capital Management Inc.

QRG Capital Management Inc. reduced its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 10.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,540 shares of the biopharmaceutical company’s stock after selling 669 shares during the period. QRG […] - 2025-03-06 11:19:16

Insmed Incorporated (NASDAQ:INSM) Shares Bought by Sanctuary Advisors LLC

Sanctuary Advisors LLC increased its position in Insmed Incorporated (NASDAQ:INSM – Free Report) by 13.7% during the fourth quarter, HoldingsChannel.com reports. The fund owned 3,861 shares of the biopharmaceutical company’s stock after acquiring an additional 464 shares during the quarter. Sanctuary Advisors LLC’s holdings in Insmed were worth $295,000 at the end of the most […] - 2025-03-05 08:29:02

Truist Financial Corp Acquires 1,000 Shares of Insmed Incorporated (NASDAQ:INSM)

Truist Financial Corp increased its holdings in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 3.4% during the 4th quarter, HoldingsChannel reports. The fund owned 30,038 shares of the biopharmaceutical company’s stock after buying an additional 1,000 shares during the period. Truist Financial Corp’s holdings in Insmed were worth $2,074,000 as of its most […] - 2025-02-27 09:13:07

Principal Securities Inc. Grows Stock Holdings in Insmed Incorporated (NASDAQ:INSM)

Principal Securities Inc. lifted its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 55.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,139 shares of the biopharmaceutical company’s stock after buying an additional 1,120 shares during the period. Principal Securities […] - 2025-02-24 10:20:49

CIBC Asset Management Inc Acquires 247 Shares of Insmed Incorporated (NASDAQ:INSM)

CIBC Asset Management Inc grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 5.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,685 shares of the biopharmaceutical company’s stock after acquiring an additional 247 shares during […] - 2025-02-24 08:58:53

Stifel Nicolaus Issues Pessimistic Forecast for Insmed (NASDAQ:INSM) Stock Price

Insmed (NASDAQ:INSM – Get Free Report) had its price objective cut by research analysts at Stifel Nicolaus from $97.00 to $96.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. Stifel Nicolaus’ target price indicates a potential upside of 18.43% from the […] - 2025-02-23 09:09:03

Van ECK Associates Corp Sells 7,790 Shares of Insmed Incorporated (NASDAQ:INSM)

Van ECK Associates Corp reduced its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 6.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 119,234 shares of the biopharmaceutical company’s stock after selling 7,790 shares during the quarter. Van ECK Associates […] - 2025-02-17 08:52:21

Insmed (NASDAQ:INSM) Shares Down 4% Following Insider Selling

Insmed Incorporated (NASDAQ:INSM – Get Free Report)’s share price dropped 4% during trading on Monday following insider selling activity. The stock traded as low as $78.52 and last traded at $76.78. Approximately 182,250 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 1,889,847 shares. The stock had previously […] - 2025-02-12 06:15:01

JPMorgan Chase & Co. Raises Insmed (NASDAQ:INSM) Price Target to $92.00

Insmed (NASDAQ:INSM – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $83.00 to $92.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. Several other equities analysts also recently commented on INSM. HC Wainwright restated a “buy” rating and issued […] - 2025-02-10 18:07:06

Insmed Incorporated (NASDAQ:INSM) Holdings Lifted by abrdn plc

abrdn plc raised its holdings in Insmed Incorporated (NASDAQ:INSM – Free Report) by 159.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 289,653 shares of the biopharmaceutical company’s stock after acquiring an additional 178,041 shares during the quarter. abrdn plc’s holdings in Insmed […] - 2025-02-07 10:07:03

VTWO, SFM, INSM, CRDO: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Russell 2000 (Symbol: VTWO) where we have detected an approximate $816.7 million dollar outflow -- that's a 6.4% decrease week over week (f - 2025-02-06 15:52:22

Insmed Incorporated (NASDAQ:INSM) Receives $83.67 Average Target Price from Analysts

Insmed Incorporated (NASDAQ:INSM – Get Free Report) has been assigned an average rating of “Buy” from the sixteen analysts that are presently covering the firm, MarketBeat reports. Sixteen analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have covered the stock in the last year is […] - 2025-02-04 07:03:07

Insmed Incorporated (NASDAQ:INSM) Shares Acquired by KBC Group NV

KBC Group NV grew its holdings in Insmed Incorporated (NASDAQ:INSM – Free Report) by 59.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,873 shares of the biopharmaceutical company’s stock after acquiring an additional 2,563 shares during the period. KBC Group NV’s holdings […] - 2025-02-03 08:42:53

INSM institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	108,964	USD 7,151,307
2025-05-08	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	66,090	USD 4,337,487 -4.0%
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	86,162	USD 5,654,812
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	86,162	USD 5,654,812 -4.0%
2025-05-08	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,275	USD 83,678
Total =		348,653	USD 22,882,096

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer